Carregant...
Azilsartan ameliorates ox-LDL-induced endothelial dysfunction via promoting the expression of KLF2
Background: Oxidized LDL(Ox-LDL) mediated endothelial dysfunction is involved in the pathogenesis of various cardiovascular diseases, including atherosclerosis. Azilsartan is a potent agent for the treatment of hypertension as the antagonist of the angiotensin II receptor. This study will investigat...
Guardat en:
| Publicat a: | Aging (Albany NY) |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Impact Journals
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8148451/ https://ncbi.nlm.nih.gov/pubmed/33946046 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.202973 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|